share_log

HC Wainwright & Co. Reiterates Buy on Greenwich LifeSciences, Maintains $36 Price Target

Benzinga ·  Feb 28 13:23

HC Wainwright & Co. analyst Yi Chen reiterates Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and maintains $36 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment